Capital International Investors Gsk PLC Transaction History

Capital International Investors

$504 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $527,853 - $599,656	-12,553 Reduced 0.07%	19,087,689 $831 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $723,496 - $858,556	-17,984 Reduced 0.09%	19,100,242 $832 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $138 Million - $160 Million	-3,541,985 Reduced 15.63%	19,118,226 $843 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $641,353 - $713,607	-16,534 Reduced 0.07%	22,660,211 $866 Million
Q2 2021 Aug 16, 2021	BUY	$36.52 - $41.46 $102 Million - $116 Million	2,787,034 Added 14.01%	22,676,745 $903 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $77.8 Million - $90.9 Million	2,271,163 Added 12.89%	19,889,711 $710 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $37.9 Million - $44.5 Million	1,113,398 Added 6.75%	17,618,548 $648 Million
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $88.5 Million - $99.9 Million	-2,323,493 Reduced 12.34%	16,505,150 $621 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $154 Million - $177 Million	4,064,539 Added 27.53%	18,828,643 $768 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $288 Million - $433 Million	8,858,438 Added 150.0%	14,764,104 $559 Million
Q4 2019 Feb 18, 2020	BUY	$42.0 - $48.25 $258,006 - $296,399	6,143 Added 0.1%	5,905,666 $278 Million
Q3 2019 Nov 14, 2019	BUY	$40.46 - $43.52 $31.6 Million - $34 Million	781,917 Added 15.28%	5,899,523 $252 Million
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $8.48 Million - $9.19 Million	215,174 Added 4.39%	5,117,606 $205 Million
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $123 Million - $136 Million	3,188,332 Added 186.01%	4,902,432 $205 Million
Q4 2018 Feb 14, 2019	BUY	$37.8 - $42.69 $64.8 Million - $73.2 Million	1,714,100 New	1,714,100 $65.5 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account